Phase I Trial of the Monoclonal Anti-Idiotype Antibody ACA125 [abagovomab] in Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
Phase of Trial: Phase I
Latest Information Update: 22 Dec 2009
At a glance
- Drugs Abagovomab (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions
- 22 Dec 2009 Actual end date (Mar 2004) added as reported by ClinicalTrials.gov.
- 22 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jun 2008 Status changed from 'completed' to 'in progress', as reported from ClinicalTrials.gov.